March Biosciences
March Biosciences is a clinical-stage cell therapy company that focuses on developing CAR-T cell strategies to address hematological cancers. The company's lead asset, MB-105, is a CD5-targeted CAR-T cell therapy currently in Phase 1 trials in patients with refractory T-cell lymphoma and leukemia.
Tech Stack (16 technologies)
Frequently Asked Questions
What technologies does March Biosciences use?+
March Biosciences uses 16 technologies including Elementor, WordPress, core-js.
What industry is March Biosciences in?+
March Biosciences operates in the Biotechnology industry.
Where is March Biosciences based?+
March Biosciences is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026